Mol Ther Nucleic Acids

CRISPR-Cas9 treatment partially restores amyloid-β 42/40 in human fibroblasts with the Alzheimer's disease PSEN 1 M146L mutation.

Konstantinidis E, Molisak A, Perrin F, ..., Berezovska O, Ingelsson M

Mol Ther Nucleic Acids 28 (-) 450-461 [2022-06-14; online 2022-03-28]

NGI Short read [Service] NGI Uppsala (Uppsala Genome Center) [Service] National Genomics Infrastructure [Service]

Comprehensive RNA sequencing analysis in serum and muscle reveals novel small RNA signatures with biomarker potential for Duchenne Muscular Dystrophy

Coenen-Stass AML, Sork H, Gatto S, ..., Wood MJA, Roberts TC

Mol Ther Nucleic Acids - (-) - [2018-08-00; online 2018-08-00]

Bioinformatics Long-term Support WABI [Collaborative] Bioinformatics Support for Computational Resources [Service] Bioinformatics Support, Infrastructure and Training [Collaborative] NGI Stockholm (Genomics Applications) [Service] NGI Stockholm (Genomics Production) [Service] National Genomics Infrastructure [Service]

Expression analysis in multiple muscle groups and serum reveals complexity in the microRNA transcriptome of the mdx mouse with implications for therapy.

Roberts TC, Blomberg KE, McClorey G, ..., Smith CI, Wood MJ

Mol Ther Nucleic Acids 1 (-) e39 [2012-08-14; online 2012-08-14]

Bioinformatics and Expression Analysis (BEA)